WETS
ALT icon

Wealth Enhancement Trust Services’s Altimmune ALT Stock Holding History

Wealth Enhancement Trust Services’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$930 Buy
+306
New +$914 ﹤0.01% 1146

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wealth Enhancement Trust Services's ALT Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Altimmune (ALT) in Q2 2026: 306 shares worth $930. The stake represents ﹤0.01% of the portfolio and ranks #1146 among its holdings.

119 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Wealth Enhancement Trust Services held 306 shares of Altimmune worth $930 as of Q2 2026.
  • Altimmune was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Altimmune made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1146 holding.
  • 119 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.